People are always fascinated with miniaturized versions of things and cars are not an exception. Remember all of those smarts, minis and tiny fiats? Well, they are giants in comparison to the electric autos that we are going to show you today! After all, EVs are all about efficiency and zero emissions, so if you […]
Germfree’s new Class II, Type A2 Biosafety Cabinet
LAS VEGAS – December 2, 2022 – (Newswire.com)
Germfree, a Florida based company, is introducing its new line of aseptic PEC (primary engineering control) equipment at the ASHP Midyear Clinical Meeting in Las Vegas. The newly redesigned equipment includes Laminar Flow Hoods, Biological Safety Cabinets, and Cleanroom Pass-Through Boxes. These new products build on Germfree’s 60 years of aseptic PEC expertise in both the hospital compounding and pharmaceutical industries. The equipment has been designed to meet and exceed the strict cGMP and USP / regulatory requirements found in these industries.
“The USP and standards have changed the working environment for many in the compounding industry,” said Ryan Henry, Marketing and Product Segment Manager at Germfree. “We listened to our customers and responded with new designs that are ideally suited for cleanroom use, enhancing the cleanability, durability, and ergonomics that they have come to expect from our products.”
All of the new products are constructed from stainless steel, both in the work areas and on the exterior of the units. The new biosafety cabinet line features an automatic, adjustable, tempered glass sliding sash and touch screen controls that come pre-loaded with instructional videos on proper usage and care for the equipment. The laminar flow line includes touch controls and low glare LED lights integrated into the work area. Both units have a night mode setting that allows the hood to remain running during periods of non-use while reducing energy consumption.
The cleanroom pass-through boxes utilize mechanical interlocks to only allow one door to be open at a time. The active HEPA purge cycle is triggered by closing either door while the interlocks remain locked until the cycle is complete. These units have been designed with an upward door swing that reduces the equipment footprint and allows for universal installation.
“Providing aseptic environments to the hospital compounding and pharmaceutical industries has been incredibly important to Germfree going back to our founding in 1962,” said Kevin Kyle, CEO of Germfree. “We are proud to be able to continue to serve these vital industries and innovate products that prevent sterile product contamination and protect patient safety.”
About Germfree: Germfree Laboratories LLC creates environments that serve life science innovation and advance global health. The company, founded in 1962, designs, engineers and manufactures equipment and facilities to serve the compounding pharmacy, biopharmaceutical and biocontainment industries throughout the world.
Marketing and Product Segment Manager
Press Release Service
Germfree Launches New Equipment Line for Sterile Product Preparation
As you’re here on YouTube, you may want to watch “How Social Media Hacks Your Brain” –~–
Dr. Wilson discusses the roll-out of vaccines to pharmacies, school reopenings, and the potential of more travel restrictions to a…
Cornerstone Specialty Network Cornerstone Specialty Network
NEW HOPE, Pa. – December 1, 2022 – (Newswire.com)
The Toyota Tundra TRD Desert Chase one-off as developed by the company’s TRD division in collaboration with Toyota Motorsports Garage as a support truck for desert racing competitions. To be capable of conquering sandy and rocky conditions, the truck received a new suspension, wheels and tires. Today, we will discuss this unique build in detail, […]
Last year, the number of Australians taking medicinal cannabis surpassed 100,000. As access to the treatment gets easier, patient demand continues to skyrocket.
The partnership will help Consociate deliver simplified healthcare navigation to members
CHICAGO – Decem…
Cornerstone Specialty Network, LLC Cornerstone Specialty Network, LLC
NEW HOPE, Pa. – December 1, 2022 – (Newswire…
Bisu’s “lab-on-a-chip” urine and saliva analyzer is intended for both consumer and astronaut use.
TOKYO – December 1, 2022 – (Newswire.com)
Traveling in space leads to bone loss, muscle loss, and an increased risk of kidney stone formation, often starting within the first 24 hours of spaceflight as calcium levels in bone and tissue decrease and are expelled in urine. A new research experiment, selected for inclusion in the upcoming Polaris Dawn spaceflight mission, aims to show if monitoring the first urine sample in the morning could provide a simple way to track astronaut health in space. If successful, the research will provide a pathway to use compact, new inflight monitoring techniques. The day’s first urine sample typically has the highest urine calcium levels in the day and taking measurements from this sample might offer a workable way to assess in-flight bone loss and kidney stone risk. As both space accessibility and long-duration human spaceflights increase, keeping crews healthy by providing personalized, targeted countermeasures will be essential. This will require small, easy-to-use, low-power devices that can provide actionable information using easily obtainable samples of urine or saliva, such as a first-morning void.
Bisu is a startup that helps people improve their health and fitness through lab-grade testing at home. Working with former astronaut Jay Buckey, MD, Professor of Medicine and Director of the Space Medicine Innovations Lab at the Geisel School of Medicine at Dartmouth, Bisu will support the post-flight analysis of first-morning void urine samples gathered from the Polaris Dawn crew to assess the effect of spaceflight on markers of bone loss, muscle loss, and kidney stone risk. If successful, this research could pave the way for inflight monitoring with new technologies, such as the microfluidic urine and saliva analyzer Bisu has developed. Because weightlessness affects people differently, this kind of in-flight monitoring could provide targeted countermeasures.
“People will be spending longer times in space, and they may not be able to do the extensive countermeasure programs currently used on the space station,” says Prof. Jay Buckey. “We need simple ways to monitor people while they are in space so that the countermeasure program can be targeted to each person’s individual needs. This research puts us on the path toward that.”
“We’re delighted to be working with Polaris Dawn and Prof. Buckey on this pioneering research,” says Daniel Maggs, co-founder & CEO at Bisu. “This research reflects Bisu’s commitment to advancing human health by making valuable health data accessible to all – whether on Earth or in space.”
About Polaris Dawn
Polaris Dawn is the first of the Polaris Program’s three human spaceflight missions. SpaceX is targeting no earlier than March 2023 for Falcon 9’s launch of Dragon and the Polaris Dawn crew from Launch Complex 39A at NASA’s Kennedy Space Center in Florida. Polaris Dawn endeavors to reach the highest Earth orbit ever flown, attempt the first-ever commercial spacewalk, conduct extensive research to further our understanding of human health on Earth and during future long-duration spaceflights, and test Starlink’s laser-based communications in space. For more information, visit polarisprogram.com/dawn.
Bisu is a healthtech startup that provides personalized, preventative advice at home, through nutrition and hormone tests using microfluidic “lab-on-a-chip” technology. In late 2021, Bisu announced a $3.2m seed round and collaboration with ASICS, took home the Good Design Award in the wellness category, and won the US Sports & Fitness Industry Association’s startup challenge.
Bisu’s flagship product, Bisu Body Coach, is currently in beta and can be applied for at www.bisu.com.
About the Space Medicine Innovations Laboratory at the Geisel School of Medicine at Dartmouth
The Space Medicine Innovations Laboratory is devoted to solving biomedical problems presented by long-duration space flight. The lab has performed work on bone loss, decompression sickness, motion sickness, and psychological countermeasures for isolation and confinement. The lab also advances work that began with NASA into other areas of research.
Please address all press inquiries to email@example.com.
Press Release Service